2010
DOI: 10.1016/j.dld.2009.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
65
0
1

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 77 publications
(69 citation statements)
references
References 10 publications
3
65
0
1
Order By: Relevance
“…The hemostatic action of ABS is correlated with a reduction in tumor neo-angiogenesis. Topical ABS administration to gastrointestinal neoplastic tissue resulted in the control of bleeding and decreased tumor vascularization in rectal and gastric cancers [26]. Moreover, there is a close relationship between coagulation factor expression and solid tumor progression, via mechanisms other than angiogenesis.…”
Section: Yy1mentioning
confidence: 99%
See 1 more Smart Citation
“…The hemostatic action of ABS is correlated with a reduction in tumor neo-angiogenesis. Topical ABS administration to gastrointestinal neoplastic tissue resulted in the control of bleeding and decreased tumor vascularization in rectal and gastric cancers [26]. Moreover, there is a close relationship between coagulation factor expression and solid tumor progression, via mechanisms other than angiogenesis.…”
Section: Yy1mentioning
confidence: 99%
“…A phase I double-blind, randomized crossover, placebo-controlled clinical study with a 5-d washout period between the crossover periods that included healthy volunteers reported that ABS was safe [20]. Physiological cell-based coagulation was clinically managed using topical ABS to prevent and treat bleeding associated with many clinicopathological states [10,18,[26][27][28]. Erythrocyte masses are critical in the ABS-induced hemostatic protein network (Figures 4 and 5).…”
Section: Nf-κbmentioning
confidence: 99%
“…[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22] It affects not only hemostasis but also wound healing with some antibacterial properties. [7][8][16][17][18][19][34][35][36][37][38][39] Clinical conditions of ABS use are increased in course of time as hemorrhagic problems persist despite available anti-hemorrhagic interventions.…”
Section: Discussionmentioning
confidence: 99%
“…5 Since ABS is a relatively novel hemostatic agent, the experience regarding its use in distinct hemorrhagic states is expanding. [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22] ABS-induced formation of the protein network with vital erythroid aggregation covers the entire physiological hemostatic process. 6,[22][23][24] Mainly, there are distinct important components of the ABS-induced hemostatic network.…”
Section: K Ke Ey Y Wmentioning
confidence: 99%
“…[13] ABS has no toxic reactions when applied to mucosal surfaces like the mouth and through the gastrointestinal tract. [13][14][15][16][17] However, the effects of longterm and deep tissue exposure to ABS remain unclear in these studies.…”
Section: Sonuçmentioning
confidence: 99%